Preview Mode Links will not work in preview mode

ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research

Apr 30, 2019

In this interview, Freek Verheugt and Colin Berry discuss T-TIME, a randomized, double blind, placebo-controlled, parallel group, multicenter clinical trial of low-dose adjunctive alteplase during primary percutaneous coronary intervention.

Apr 22, 2019

In this interview, Spencer King and David Wilbur discuss atrial fibrillation, catheter ablation, and the results of the CABANA trial (Catheter Ablation vs Antiarrhythmic Drug Therapy in Atrial Fibrillation).